CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Vascarta Announces NIH Phase I clinical study of VAS-101 in sickle cell disease begins

Phase 1VAS-101

Read the original article

Published by PR Newswire Biotech on August 19, 2026 6:18 PM

Read Original